Dr Reddys Share Price Highlights: Dr. Reddys Stock Price History
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Tech Mahindra Share Price Highlights: Tech Mahindra Stock Price History
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
RIL Share Price Highlights: RIL Stock Price History
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Grasim Inds Share Price Highlights: Grasim Inds. Stock Price History
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
LTIMindtree Share Price Highlights: LTIMindtree Stock Price History
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Adani Ent Share Price Highlights: Adani Ent. Stock Price History
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
IndusInd Bank Share Price Highlights: IndusInd Bank Stock Price History
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Titan Company Share Price Highlights: Titan Company Stock Price History
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Eicher Motors Share Price Highlights: Eicher Motors Stock Price History
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Aurobindo Pharma among 9 mid-cap stocks to hit 52-week highs & rally up to 20% in a month
The Sensex fell 372 points on Monday, but nine BSE Midcap stocks touched fresh 52-week highs, signalling resilient investor confidence. Bank of Maharashtra, Thermax, Bharat Forge, Oracle Financial Services and Laurus Labs were among the key outperformers despite broader market weakness.